Cancer immunotherapy has transformed the landscape of oncology, offering powerful tools that train the body’s own immune system to fight cancer. RNA-Seq plays a pivotal role in precision oncology and
RNA sequencing (RNA-Seq) has become an indispensable tool for cancer researchers. Unlike traditional methods, RNA-Seq provides a dynamic snapshot of the complete transcriptome, revealing not just the presence of specific
21.05.2025, Vienna, Austria — Lexogen, a leader in RNA sequencing technologies, is excited to announce the launch of the miRVEL Discovery Small RNA-Seq Library Prep Kit, an advanced solution for
RNA sequencing (RNA-Seq) is a powerful tool that can be applied at various stages of the drug discovery and development workflow, from target identification to studying drug effects, mode-of-action, and
RNA sequencing (RNA-Seq) has emerged as a cornerstone of cancer research and drug discovery, providing crucial insights for the development of novel therapies. By comprehensively profiling expression patterns, splice variants,
Next generation sequencing (NGS) has significantly advanced omics research, enabling high-throughput sequencing of DNA and RNA at unprecedented scale and depth offering a powerful tool to unravel the genetic basis
Today’s scientific landscape for drug discovery is extremely fast-paced: new technologies emerge constantly accelerating discoveries. Time is of the essence and researchers are seeking innovative ways to integrate more complex
Small molecule drugs, or low molecular weight compounds, are used as therapeutics to modulate physiological processes to treat or prevent diseases. The discovery of novel small molecule drugs is one
Traditional drug discovery often relies on single endpoint assays using visual markers, which can be challenging to quantify and limited in their ability to capture the complexity of biological systems.
Introduction Drug discovery and development is an elaborate and lengthy process, and researchers are constantly seeking innovative tools to unravel the complexities of human biology further and accelerate
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna, Austria
Telephone:
+43 (0) 1 345 1212
Sales support:
+43 (0) 1 345 1212-42
Technical support:
+43 (0) 1 345 1212-41
Working hours: 9:00 – 17:00 (CET)
Fax: +43 (0) 1 345 1212-99
Email: info@lexogen.com
Company number: FN 297318 h
VAT number: ATU63622048
Lexogen, Inc.
51 Autumn Pond Park
Greenland, NH 03840, US
Telephone:
+1-603-431-4300 ext.0
+1-877-Lexogen
(+1-877-539-6436) ext. 0
Sales inquiries:
Northeast: +1-312-978-6413
Southeast: +1-615-968-3325
Northwest: +1-415-726-4318
Southwest: +1-520-934-0678
Technical support:
+1-949-767-1631
(Working hours: 9:00 – 17:00 (EST))
+1-603-498-1666
(Working hours: 7:30 – 15:30 (CST))
Fax: +1-603-431-4333
Lexogen Newsletter
Subscribe to our mailing list to be among the first to get updates from us!
Copyright © 2026 Lexogen GmbH. All rights reserved | Impressum | Privacy Policy | Terms and Conditions | Whistleblowing
Product Short Description
PRICE
Product Short Description
PRICE
Product Short Description
PRICE
